JILLIAN KIMBRELL: Open Payments
NPI 1275892705 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 46 payments from 14 companies in 2025. Trend: 2023 $1,685 · 2024 $1,141 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $184 |
| Amgen Inc. | 3 | $141 |
| Lilly USA, LLC | 10 | $139 |
| Boston Scientific Corporation | 1 | $125 |
| ABBVIE INC. | 4 | $79 |
| GlaxoSmithKline, LLC. | 4 | $62 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Renalytix AI, Inc. | 2 | $31 |
| Exact Sciences Corporation | 2 | $28 |
Products named: Intracept, KRYSTEXXA, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, FARXIGA, Auvelity, UBRELVY.
Industry payments across MS — which companies pay providers there.
